Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2008

01-08-2008 | Original Paper

Diet, Lifestyle and Gender in Gastro-Esophageal Reflux Disease

Authors: Maria Pina Dore, Emmanouil Maragkoudakis, Ken Fraley, Antonietta Pedroni, Vincenza Tadeu, Giuseppe Realdi, David Y. Graham, Giuseppe Delitala, Hoda M. Malaty

Published in: Digestive Diseases and Sciences | Issue 8/2008

Login to get access

Abstract

Background Studies indicate that gastro-esophageal reflux disease (GERD) is associated with obesity, smoking, esophagitis, diet, and lifestyle. Aim To identify risk factors associated with GERD among patients presenting to a tertiary GI clinic in Italy. Methods Patients with a first diagnosis of GERD based on heartburn and/or regurgitation and/or esophagitis at the endoscopic examination were enrolled. A control group with neither GERD symptoms nor esophagitis was enrolled from the same hospital. Each subject completed a questionnaire including demographic information, lifestyle (e.g., exercise, alcohol, coffee, chocolate, and soda consumption, smoking, having large meals), and frequency of bowel movement. For each participant the body mass index (BMI) was calculated. Results Five hundred subjects were enrolled including 300 GERD patients and 200 controls. Females had significantly higher prevalence of GERD than males (66 vs. 48%, P = 0.001, OR = 2.1, 95% CI = 1.5–3.1). There was an inverse relationship between the level of education and presence of GERD (76% of GERD patients has completed only elementary school (OR = 2.1, 95% CI = 1.7–4.9). Obesity (BMI of ≥95th percentile for their age/gender specific) was significantly related to GERD (OR = 1.8, P = 0.01). None of the other variables studied showed significant associations with GERD. Logistic regression analysis showed that BMI ≥95th percentile, gender, and low education level were significant risk factors for GERD. Conclusions Understanding the epidemiology and risk factors for GERD in a region is the first step in designing prevention and treatment strategies.
Literature
1.
go back to reference Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J (2004) Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex. Scand J Gastroenterol 39:1040–1045PubMedCrossRef Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J (2004) Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex. Scand J Gastroenterol 39:1040–1045PubMedCrossRef
2.
go back to reference Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J (2004) Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 53:1730–1735PubMedCrossRef Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J (2004) Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 53:1730–1735PubMedCrossRef
3.
go back to reference Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J (2003) Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 290:66–72PubMedCrossRef Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J (2003) Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 290:66–72PubMedCrossRef
4.
go back to reference Watanabe Y, Fujiwara Y, Shiba M, Watanabe T, Tominaga K, Oshitani N, Matsumoto T, Nishikawa H, Higuchi K, Arakawa T (2003) Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol 38:807–811PubMedCrossRef Watanabe Y, Fujiwara Y, Shiba M, Watanabe T, Tominaga K, Oshitani N, Matsumoto T, Nishikawa H, Higuchi K, Arakawa T (2003) Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol 38:807–811PubMedCrossRef
5.
go back to reference Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III (1999) Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 106:642–649PubMedCrossRef Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III (1999) Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 106:642–649PubMedCrossRef
6.
go back to reference Lee KS, Park CY, Meng KH, Bush A, Lee SH, Lee WC, Koo JW, Chung CK (1998) The association of cigarette smoking and alcohol consumption with other cardiovascular risk factors in men from Seoul, Korea. Ann Epidemiol 8:31–38PubMedCrossRef Lee KS, Park CY, Meng KH, Bush A, Lee SH, Lee WC, Koo JW, Chung CK (1998) The association of cigarette smoking and alcohol consumption with other cardiovascular risk factors in men from Seoul, Korea. Ann Epidemiol 8:31–38PubMedCrossRef
7.
go back to reference Dore MP, Pedroni A, Pes GM, Maragkoudakis E, Tadeu V, Pirina P, Realdi G, Delitala G, Malaty HM (2007) Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease. Dig Dis Sci 52:463–468PubMedCrossRef Dore MP, Pedroni A, Pes GM, Maragkoudakis E, Tadeu V, Pirina P, Realdi G, Delitala G, Malaty HM (2007) Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease. Dig Dis Sci 52:463–468PubMedCrossRef
8.
go back to reference Rey E, Elola-Olaso CM, Rodriguez-Artalejo F, Locke GR III, Diaz-Rubio M (2006) Prevalence of atypical symptoms and their association with typical symptoms of gastroesophageal reflux in Spain. Eur J Gastroenterol Hepatol 18:969–975PubMedCrossRef Rey E, Elola-Olaso CM, Rodriguez-Artalejo F, Locke GR III, Diaz-Rubio M (2006) Prevalence of atypical symptoms and their association with typical symptoms of gastroesophageal reflux in Spain. Eur J Gastroenterol Hepatol 18:969–975PubMedCrossRef
9.
go back to reference Cameron AJ, Lagergren J, Henriksson C, Nyren O, Locke GR III, Pedersen NL (2002) Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 55–59 Cameron AJ, Lagergren J, Henriksson C, Nyren O, Locke GR III, Pedersen NL (2002) Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 55–59
10.
go back to reference Hampel H, Abraham NS, El-Serag HB (2005) Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143:199–211PubMed Hampel H, Abraham NS, El-Serag HB (2005) Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143:199–211PubMed
11.
go back to reference Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J (2004) Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 53:1730–1735PubMedCrossRef Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J (2004) Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 53:1730–1735PubMedCrossRef
12.
go back to reference Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ (2006) Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 130:639–649PubMedCrossRef Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ (2006) Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 130:639–649PubMedCrossRef
13.
go back to reference Veugelers PJ, Porter GA, Guernsey DL, Casson AG (2006) Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus 19:321–328PubMedCrossRef Veugelers PJ, Porter GA, Guernsey DL, Casson AG (2006) Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus 19:321–328PubMedCrossRef
14.
go back to reference Mohammed I, Cherkas LF, Riley SA, Spector TD, Trudgill NJ (2003) Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut 52:1085–1089PubMedCrossRef Mohammed I, Cherkas LF, Riley SA, Spector TD, Trudgill NJ (2003) Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut 52:1085–1089PubMedCrossRef
15.
go back to reference Isolauri J, Laippala P (1995) Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 27:67–70PubMedCrossRef Isolauri J, Laippala P (1995) Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 27:67–70PubMedCrossRef
16.
go back to reference Kotzan J, Wade W, Yu HH (2001) Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a medicaid population. Pharm Res 18:1367–1372PubMedCrossRef Kotzan J, Wade W, Yu HH (2001) Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a medicaid population. Pharm Res 18:1367–1372PubMedCrossRef
17.
go back to reference Kostikas K, Papaioannou AI, Gourgoulianis KI (2006) BMI and gastroesophageal reflux in women. N Engl J Med 354:2340–2348CrossRef Kostikas K, Papaioannou AI, Gourgoulianis KI (2006) BMI and gastroesophageal reflux in women. N Engl J Med 354:2340–2348CrossRef
18.
go back to reference Kahrilas PJ, Gupta RR (1990) Mechanisms of acid reflux associated with cigarette smoking. Gut 4–10 Kahrilas PJ, Gupta RR (1990) Mechanisms of acid reflux associated with cigarette smoking. Gut 4–10
19.
go back to reference Vitale GC, Cheadle WG, Patel B, Sadek SA, Michel ME, Cuschieri A (1987) The effect of alcohol on nocturnal gastroesophageal reflux. JAMA 258:2077–2079PubMedCrossRef Vitale GC, Cheadle WG, Patel B, Sadek SA, Michel ME, Cuschieri A (1987) The effect of alcohol on nocturnal gastroesophageal reflux. JAMA 258:2077–2079PubMedCrossRef
20.
go back to reference Pehl C, Waizenhoefer A, Wendl B, Schmidt T, Schepp W, Pfeiffer A (1999) Effect of low and high fat meals on lower esophageal sphincter motility and gastroesophageal reflux in healthy subjects. Am J Gastroenterol 94:1192–1196PubMedCrossRef Pehl C, Waizenhoefer A, Wendl B, Schmidt T, Schepp W, Pfeiffer A (1999) Effect of low and high fat meals on lower esophageal sphincter motility and gastroesophageal reflux in healthy subjects. Am J Gastroenterol 94:1192–1196PubMedCrossRef
21.
go back to reference Hills JM, Aaronson PI (1991) The mechanism of action of peppermint oil on gastrointestinal smooth muscle. Gastroenterology 101:55–65PubMed Hills JM, Aaronson PI (1991) The mechanism of action of peppermint oil on gastrointestinal smooth muscle. Gastroenterology 101:55–65PubMed
22.
go back to reference Murphy DW, Castell DO (1988) Chocolate and heartburn: evidence of increased esophageal acid exposure after chocolate ingestion. Am J Gastroenterol 83:633–636PubMed Murphy DW, Castell DO (1988) Chocolate and heartburn: evidence of increased esophageal acid exposure after chocolate ingestion. Am J Gastroenterol 83:633–636PubMed
23.
go back to reference Brazer SR, Onken JE, Dalton CB, Smith JW, Schiffman SS (1995) Effect of different coffees on esophageal acid contact time and symptoms in coffee-sensitive subjects. Physiol Behav 57:563–567PubMedCrossRef Brazer SR, Onken JE, Dalton CB, Smith JW, Schiffman SS (1995) Effect of different coffees on esophageal acid contact time and symptoms in coffee-sensitive subjects. Physiol Behav 57:563–567PubMedCrossRef
24.
go back to reference Hamoui N, Lord RV, Hagen JA, Theisen J, Demeester TR, Crookes PF (2006) Response of the lower esophageal sphincter to gastric distention by carbonated beverages. J Gastrointest Surg 10:870–877PubMedCrossRef Hamoui N, Lord RV, Hagen JA, Theisen J, Demeester TR, Crookes PF (2006) Response of the lower esophageal sphincter to gastric distention by carbonated beverages. J Gastrointest Surg 10:870–877PubMedCrossRef
25.
go back to reference Pehl C, Pfeiffer A, Wendl B, Kaess H (1998) Different effects of white wine and red wine on lower esophageal sphincter pressure and gastroesophageal reflux. Scand J Gastroenterol 33:118–122PubMedCrossRef Pehl C, Pfeiffer A, Wendl B, Kaess H (1998) Different effects of white wine and red wine on lower esophageal sphincter pressure and gastroesophageal reflux. Scand J Gastroenterol 33:118–122PubMedCrossRef
26.
go back to reference Pehl C, Wendl B, Pfeiffer A, Schmidt T, Kaess H (1993) Low-proof alcoholic beverages and gastroesophageal reflux. Dig Dis Sci 38:93–96PubMedCrossRef Pehl C, Wendl B, Pfeiffer A, Schmidt T, Kaess H (1993) Low-proof alcoholic beverages and gastroesophageal reflux. Dig Dis Sci 38:93–96PubMedCrossRef
27.
go back to reference Jozkow P, Wasko-Czopnik D, Medras M, Paradowski L (2006) Gastroesophageal reflux disease and physical activity. Sports Med 36:385–391PubMedCrossRef Jozkow P, Wasko-Czopnik D, Medras M, Paradowski L (2006) Gastroesophageal reflux disease and physical activity. Sports Med 36:385–391PubMedCrossRef
28.
go back to reference DeVault KR, Castell DO (2005) Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100:190–200PubMedCrossRef DeVault KR, Castell DO (2005) Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100:190–200PubMedCrossRef
29.
go back to reference Kaltenbach T, Crockett S, Gerson LB (2006) Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med 166:965–971PubMedCrossRef Kaltenbach T, Crockett S, Gerson LB (2006) Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med 166:965–971PubMedCrossRef
Metadata
Title
Diet, Lifestyle and Gender in Gastro-Esophageal Reflux Disease
Authors
Maria Pina Dore
Emmanouil Maragkoudakis
Ken Fraley
Antonietta Pedroni
Vincenza Tadeu
Giuseppe Realdi
David Y. Graham
Giuseppe Delitala
Hoda M. Malaty
Publication date
01-08-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-0108-7

Other articles of this Issue 8/2008

Digestive Diseases and Sciences 8/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.